Vistagen Therapeutics announces encouraging results from its Phase 2A clinical study of PH80, a neuroactive nasal spray designed for the acute management of premenstrual dysphoric disorder (PMDD). PMDD is a severe, sometimes disabling extension of premenstrual syndrome (PMS). PMDD symptoms can be extremely limiting to daily functioning and can cause extreme mood shifts that can disrupt daily life and damage relationships. The…
TMRW Life Sciences, a New York-based company specializing in fertility technology has received a CE Mark for its its CryoRobot Select (CRS) platform. This regulatory approval follows the platform’s clearance by the U.S. Food and Drug Administration (FDA) in November 2022, making it compliant for commercial use both in the United States and in CE Mark-required regions, including the EU and the…
NK:IO, a startup working on natural killer (NK) cell biology applied to the development of exceptionally potent, off-the-shelf cell therapies targeting solid tumours, has raised an additional £1.2M in funding to advance its work. This brings total equity financing to £3.2M and will enable the company to reach key milestones in progressing its differentiated NK cell therapy candidates into development. The £3.2M…
As we highlighted last week, September is Gynecological Cancer Awareness Month. After exploring the landscape of challenges and opportunities in gynecological cancer treatment, this week we’re zeroing in on Ovarian Cancer. Specifically, we’ll introduce you to the startups making waves in diagnostics and care for this often-fatal condition. A Quick Recap: What is Ovarian Cancer? Ovarian cancer originates in the ovaries, the female reproductive glands responsible…
Yes.. It is indeed that time of the year again… YC Demo Day is around the corner and as always we made time to look through the hundreds of startups who just graduated from Y Combinator (Batch S22) to share our picks of companies, who we believe can truly make an impact in the world of healthcare innovation. Curious who made our…
Athena Alliance, a professional development community focused on preparing women for executive and board roles, has announced an additional $2M in seed funding, bringing its total funding to $2.5M within its first 2.5 years of operation. Athena Alliance provides a range of services including on-demand learning, one-on-one executive coaching, and both virtual and in-person networking opportunities. The funding round was led by…
Caldera Medical, a Los Angeles-based medical device company has announced the completion of its acquisition of Atlantic Therapeutics, an Ireland-based medical device provider specializing in non-invasive pelvic floor strengthening and nerve-stimulating solutions. Caldera Medical specializes in products for the treatment of Stress Urinary Incontinence, Pelvic Organ Prolapse, Polyps, and Fibroids. The company is committed to improving the quality of life for women…
Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page. Highlights UK-based bladder care startup Jude adds $4.24M in seed funding setting sights on U.S. market. Pumpspotting secures $2.2M in funding to advance breastfeeding support in workplaces and beyond. Miri raises $1.2M in…
